HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The reinfusion of blood and the administration of dalargin in experimental hemorrhagic shock].

Abstract
In acute experiment on 95 adult rabbits it was determined that during the subdivided blood exfusion from femoral artery in the volume of (16 + 1) ml/kg the reversible hemorrhagic shock occurs and the animals survive without the hemorrhage compensation. The increase of hemorrhage volume up to (23 + 3) ml/kg leads to lethal hemorrhagic shock. The heparinized blood reinfusion in the early period promotes the survival of the whole of animals, in the late period it promotes trustworthy their life span increase. Under the influence of dalargin intravenous infusion in the dose of 0.1 mg/kg after the blood reinfusion in the late period of shock all the animals survived. Intravenous infusion of dalargin is expedient for the increase of the transfusion therapy effectiveness in the late period of hemorrhagic shock.
AuthorsD M Sherman, V M Trach
JournalKlinicheskaia khirurgiia (Klin Khir (1962)) Issue 9 Pg. 38-41 ( 1994) Ukraine
Vernacular TitleReinfuziia krovi i vnutrivennoe vvedenie dalargina pri éksperimental'nom gemorragicheskom shoke.
PMID7602944 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Enkephalin, Leucine-2-Alanine
  • enkephalin-Leu, Ala(2)-Arg(6)-
Topics
  • Animals
  • Blood Transfusion, Autologous
  • Combined Modality Therapy
  • Enkephalin, Leucine-2-Alanine (administration & dosage, analogs & derivatives)
  • Evaluation Studies as Topic
  • Hemodynamics
  • Rabbits
  • Shock, Hemorrhagic (mortality, physiopathology, therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: